CVE-2023-51633

Centreon sysName Cross-Site Scripting Remote Code Execution Vulnerability

Description

Centreon sysName Cross-Site Scripting Remote Code Execution Vulnerability. This vulnerability allows remote attackers to execute arbitrary code on affected installations of Centreon. User interaction is required to exploit this vulnerability. The specific flaw exists within the processing of the sysName OID in SNMP. The issue results from the lack of proper validation of user-supplied data, which can lead to the injection of an arbitrary script. An attacker can leverage this vulnerability to execute code in the context of the service account. Was ZDI-CAN-20731.

Category

9.6
CVSS
Severity: Critical
CVSS 3.1 •
CVSS 3.0 •
EPSS 2.42% Top 20%
Third-Party Advisory zerodayinitiative.com
Affected: Centreon Centreon
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-51633?
CVE-2023-51633 has been scored as a critical severity vulnerability.
How to fix CVE-2023-51633?
To fix CVE-2023-51633, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-51633 being actively exploited in the wild?
It is possible that CVE-2023-51633 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-51633?
CVE-2023-51633 affects Centreon Centreon.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.